Correlation Between Hepion Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Hepion Pharmaceuticals and Blueprint Medicines
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hepion and Blueprint is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 3.48 times less return on investment than Blueprint Medicines. But when comparing it to its historical volatility, Hepion Pharmaceuticals is 1.05 times less risky than Blueprint Medicines. It trades about 0.06 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 8,277 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 1,110 from holding Blueprint Medicines Corp or generate 13.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Blueprint Medicines Corp |
Hepion Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Hepion Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |